EUVIMED · CrossrefZeitschrift
Mediastinum
ISSN 2522-6711 · AME Publishing Company
Neueste Artikel
AB001. Comparison of the performance of clinical classification systems for myasthenia gravis relapse after thymoma resection
AB002. New-onset myasthenia gravis after thymoma resection and subsequent recurrence/metastasis: a multicenter cohort
AB003. Adjuvant treatment pathways and disease control after R0 resection for thymic squamous cell carcinoma
AB004. Clinical and surgical implications of the International Thymic Malignancy Interest Group Mediastinal Classification Consensus in a Peruvian Reference Hospital: a retrospective comparative analysis with the classic model
AB005. Updated survival implications of post-operative radiotherapy after complete resection of thymoma in the United States National Cancer Database
AB006. Atypical thymoma mimicking a left upper lobe pulmonary mass: a case report
AB007. Is phrenic nerve sparing worthwhile for phrenic-involved thymic epithelial tumors: a retrospective cohort study
AB008. Final analysis from PECATI phase 2 trial: lenvatinib in combination with pembrolizumab in pretreated advanced B3-thymoma and thymic carcinoma
AB009. Influence of thymus or thymoma weight on improvement of myasthenic symptoms: a single-center retrospective analysis
AB010. Pattern of c-Met protein expression in thymic neuroendocrine tumors
AB011. Clinicopathological characteristics of thymic neuroendocrine tumors from the French RYTHMIC Network: focus on the newly defined G3 subtype
AB012. Limited assessment of patient-reported outcomes in clinical trials of thymic epithelial tumors despite the relevance of safety findings: a systematic review
AB013. A mediastinal hat trick—synchronous diagnosis of three rare mediastinal disorders
AB014. Ectopic parathyroid associated with a thymic cyst, identified due to hemorrhage and correction of hypercalcemia: a case report and surgical considerations
AB015. Establishing a multidisciplinary hyperthermic intrathoracic chemotherapy program for stage IVA thymoma in a hyperthermic intrathoracic chemotherapy-Naïve Center: a pilot experience
AB016. Pilot feasibility of cell-free DNA fragmentomics and methylomics in thymic epithelial tumors
AB017. Clinical activity and tolerability of bintrafusp alfa in recurrent thymic epithelial tumors
AB018. Management of recurrent thymic malignancies after thymectomy: delayed treatment and long-term survival
AB019. Neuroendocrine thymic tumor: case report
AB020. A pleural dissemination burden-based p-staging framework for prognostic stratification in de novo M1a thymoma
AB021. Prognostic implications of non-anatomic factors in resected thymoma according to the TNM 9th edition: WHO histologic type and myasthenia gravis
AB022. Dynamic diffusion slider software approach gives better characterisation and prognostication of mediastinal pathology
AB023. Innovation to maximize insight gained—education committee approach to better clinical decisions
AB024. Mixed histology is a prognostic factor for recurrence in completely resected thymic epithelial tumours: a multicentre retrospective study
AB025. Deep learning model predicts recurrence in thymic epithelial tumours: a multicentre study
AB026. Non-therapeutic thymectomy: rate determination, potential causes, and retrospective analysis of preoperative imaging findings in a Chilean cohort (2015–2025)
AB027. Paraneoplastic diseases in patients with thymic epithelial tumours: findings from the nation-wide Danish thymic epithelial tumor database
AB028. Predominance of minimally invasive surgery in the management of thymic neoplasms at a Latin American cancer center: a single-institution cohort
AB029. Targeting the CXCR4/CXCL12 axis as a strategy to reprogram the macrophage landscape in thymic epithelial tumors: a translational framework
AB030. Incidence and treatment of recurrent thymic epithelial tumors following initial surgical resection: a 30-year single-center retrospective cohort study
EUVIMED